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Abstract 
Background 
In general hospital settings, acute admission patients with confusion, whether 
due to dementia, delirium or other cause often get a worse outcome compared with 
other patients. In addition, unidentified dementia or cognitive impairment is frequent 
in general hospital, which contributes to some healthcare outcomes such as length of 
stay, mortality and re-admission for the dementia population. 
A systematic review on prevalence, associations and outcomes of dementia in 
older people admitted to general hospital, which has been the only review that covers 
a comprehensive comparison of heterogeneous studies so far. 
Methods 
 
Systematic searches were conducted using MEDLINE, EMBASE, PsyInfo, 
CINAHL and the Cochrane library. All types of studies were included in the reviews. 
Only those studies published in English and targeted in people aged 65 years and 
above were involved. Meta-analysis was performed with Cochrane’s Review 
Manager5.3. Heterogeneity of included studies would be measured by I
2
 which can 
explain the percentage of the variability in effect due to heterogeneity. 
The data come from a routine clinical identification programme called 
Cognitive Geriatric Assessment research (CGA), which was a retrospective cohort 
study conducted with patients aged above 65 years’ old who have an admission to 
acute hospital. Patients with admission between 01 January 2012 and 31 December 
2012 were all involved in the study. The data analyse were conducted using SAS 
version9.3 provided by the server of the Safe Haven of Health Informatics Centre 
(HIC) in Dundee University. Characteristic differences across the people were 
checked for significance using  tests and ANOVA tests. Kaplan-Meier procedures 
and Log-Rank Tests were conducted to describe the median survival time and 
survival difference. Cox’s proportional hazards regression model was employed to 
investigate the association between death and survival time with multiple predictors. 
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To check the validity of the survival model, Kolmogorov-Type Supremum Tests (49) 
with the ‘assess’ statements in SAS were also added in the final model.  
Results 
There were total of 14 papers included in the systematic review. Meta- 
analysis of 6 papers with 30 days’ mortality showed that people with dementia had 
significantly greater mortality by 11% (95%CI: 6%-16%, p<0.001) compared with 
people without dementia, though with significant heterogeneity (I
2
= 68%, p= 
0.01).The longest stay was 26.1 days; the minimum length was 4.6 days. 
In unadjusted Cox’s model, the hazard of death was associated with 
dementia, clinical delirium, FSD and CI as well as some demographic factors. When 
adjusting for the four conditions, age, gender CCI and SIMD, the hazard of death for 
patients with dementia was estimated to decrease slightly from 1.42 unadjusted to 
1.17 with a 95% confidence interval of 1.00 -1.38 . Similarly, those with clinical 
delirium had 1.23 times greater hazard ratio (HR) to death (95% CI: 1.10-1.37) 
which also declined from 1.39 when no factors were adjusted for. Although FSD and 
CI were shown to significantly increase the risk of death with hazard ratios of 1.53 
and 1.35 by themselves, they were not significant predictors anymore in the adjusted 
model.  Age, male gender and CCI always significantly contributed to predicting the 
hazard of death no matter what was adjusted for. 
Conclusion 
During admissions for the elderly, the four confusion conditions are prevalent 
worldwide. Each confusion condition is related to worse outcomes in general hospital 
settings. People with dementia, delirium, cognitive impairment and FSD always do 
badly in terms of survival time. Dementia and delirium indeed have independent 
significant influence on mortality when other factors are taken account of in an 
adjusted Cox regression model. It is crucial to identify CI in a timely way, which 
potentially could decrease mortality. For patients who have already been diagnosed 
with some chronic diseases, it will also benefit them if their CI can be detected early 
and possible treatment earlier. 
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1. Introduction 
1.1 Background 
As a disease associated with old age, dementia has become a concern not only 
to the older people but also to the majority of the general citizens. The worldwide 
prevalence of dementia among the elderly is rapidly growing. It is estimated that 
about 35 million people living with dementia globally in 2010, and this figure is 
projected to grow further at two times in every year. Elderly people with cognition 
impairment suffered from disability, low life expectancy and low quality of life. 
Sometimes, they are even misunderstood by their friends. Caring for relatives or 
patients with dementia or deliriumis also a huge task. Besides, the medical costs for 
formal and social care for these groups of people are huge. 
People with ages always suffered problems with memory and cognitive 
abilities, which are often considered as normal for the age. Unfortunately, the early 
stage of dementia is usually marked by increasing deterioration in cognition. Some 
cognitive impairment does not reach the severity of dementia. The slow onset of 
confusion may cause the neglect on diagnosis of dementia. Delirium is an urgent 
symptom, which may cause by varied cause such as adverse effects, infection and 
intra-cranial. Patients are often misdiagnosed as dementia rather than having a 
medical problem. The similar confusion symptom and course of disease may them 
easily overlap and mix together. 
According to official statistics, there are 850,000 people living with dementia 
in the UK now and this figure is estimated to rise to over two million by 2051 if no 
action has been taken(1). In general hospital settings, acute admission patients with 
confusion, whether due to dementia, delirium or other causeoften have a worse 
outcome compared with other patients. For example, dementia patients are shown to 
do badly in survival time in many studies (2, 3). The mortality from dementiais 
estimated to be 4 times thatof no-dementia(4). Unidentified dementia, delirium or 
cognitive impairment is frequent in general hospital, which contributes to some 
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healthcare outcomes such as length of stay, mortality and re-admission for the 
dementia population. In one study, the 6-month mortality for patients with 
undetected delirium was three times than patients for whom delirium was 
identified(5). Besides, the reality that “dementia” is always thought as a common co-
morbidity in acute hospitaladmission but is rarely recorded as a primary reason for 
admission also means there is a lack of data in these studies. 
A systematic review has been done before to examine the range of diagnostic 
tools used in general hospital settings, also the prevalence and associations of 
dementia under general hospital settings. Finally, fourteen papers were identified. 
The prevalence of dementia was ranged largely. Less than 30% of studies screened 
for delirium or depression, which may cause misclassification for having dementia. 
This review was valuable for us to highlight the gaps in the literature and assess the 
method used in the work which has published. But some limitations such as less 
rigorous searching procedure and outdated papers involved all raise up to conduct a 
further review. 
1.2 Aims and Objective 
Our aim was systematically review the prevalence and outcomes of elderly 
who have confusion conditions who admitted to the general hospital. Also try to 
clarify the effect of each confusion condition on patients’ outcomes by analysing a 
dataset.  
1.3 Systematic Review 
1.3.1 Previous Study 
A systematic review about prevalence, associations and outcome of dementia 
in older people admitted to general hospital,published in 2011by 
Mukadam(6),wasfound to be relevant to my study. This is the only review that 
covers a comprehensive comparison of heterogenetic studies. But in this paper there 
are several weaknessesthat cannot be ignored. Firstly, they just used two keywords 
“cognitive impairment” and “dementia” as the terms in the searching stage, which 
was too focused and ignored outcomes. Second, dementia is a common condition that 
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affects about 800,000 people in the UK(7) andthe risk of developing dementia will 
increase as you get older, and the condition usually occurs in people over the age of 
65. Several studies have explored prevalence of dementia before. In totally, there 
were over 30% of people over 65 will develop dementia (8-10). However, the age 
cut-off point which was used by Mukadam(6)was 55 years.For geriatric conditions, 
such an age boundary is too young to get a satisfactory search result. Third, the paper 
only included the studies which used validated diagnosis criteria for dementia. It 
excluded the dementia population without a formal diagnosis.Furthermore, we can 
find that among 14 papers presented in Mukadam’s(6) review, six of them were 
published before 1994. It is therefore essential to do a more thorough review to find 
studies conducted with dementia for the more recent 20 years.  
The proposed study will use several alternative MeSH terms within the 
search, which might be expected to include important articles. Also by including 
patients with all forms of cognitive impairment regardless of whether they have a 
formal diagnosis of dementia can be representative of the whole dementia population 
rather than those solely with a formal diagnosis. 
1.3.2 Methods 
The review was carried out as a follow-up to a study on Cognitive Geriatric 
Assessment (CGA) on patients in Fife, Scotland which was conducted from 2011. 
All people aged 65 years and over admitted as an emergency to NHS Fife have been 
assessed for functional and cognitive ability, screened for delirium, and had their 
socio-environmental situation documented. 
Search strategy and selection criteria 
Systematic searches were conducted using electronic databases from 1994 to 
October 2014, including MEDLINE (Medical Literature Analysis and Retrieval 
System Online), EMBASE (ExcerptaMedicadataBASE), PsyInfo, CINAHL EBSCO 
(Cumulative Index to Nursing and Allied Health) and the Cochrane library. The 
following MeSH terms were combined and used:  
(“Dementia” or “Alzheimer Disease” or “mild cognitive impairment” or 
“cognitive impairment” or “cognition disorder”)  
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AND 
(“Hospitals, general” or “hospitals” or “hospital units” or “emergency 
services, hospital” or emergency treatment” or “emergency medical services” or 
“patient admission” or “hospitalisation”)  
AND 
 (“Patient outcome assessment” or “outcome assessment (health care)” or 
“patient readmission” or “patient discharge” or “patient transfer” or “comorbidity”) 
All types of studies (for example, cohort and cross-sectional studies) were 
included in our reviews. Only those studies published in English and targeted in 
people aged 65 years and above were included.  
Inclusion criteria 
• Studies focused on people aged 65 years and above (if the paper explore more 
widen age range, we would also keep the paper, but just extracted outcome of 
people aged 65 and above). 
• Studies were published in English. 
• Studies were published from 1994 onwards. 
• Studies conducted in general hospital.  Emergency wards within the general 
hospital were also included. 
Exclusion criteria 
For the patients with hip fracture, cognitive impairment (including dementia 
and delirium) rate is believed to be as much as three to six times higher than other 
general hospitalized older patients(11), so the studies involving hip fracture and any 
surgical emergencies were excluded. 
Study selection 
All the search results will be exported into EndNote X6 from each database. 
The results will first be selected by deleting the duplicates by EndNotesystematically. 
And then a selection based on title and abstract will be done. In case of uncertainty 
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for inclusion, titles and abstracts will be assessed for inclusion by two reviewers. 
Discrepancies in inclusion will be resolved by discussion with Professor Peter 
Donnan (P.D.). Next, those studies still remaining based on title and abstract will be 
accessed in full text and be appraised further.  
 
Figure 1.1Study flowchart 
1.3.3 Data Extraction and Quality Assessment 
Data extraction 
Detailed information about each studywas extracted with disagreements 
resolved by consensus with P.D. Several data extraction forms (Table 1.1to Table 
1.4)were designed to collect information on characteristics of each study. Variables 
of the formsinclude setting and type of study, age range of the samples, sample size, 
the assessment tools used, prevalence of dementia/delirium/cognitive impairment, 
length of hospital stay, mortality and rehospitalisation rate.  
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Quality assessment 
Selected studies for methodological quality were appraised by using the 
assessment tool STROBE Statement(12). The STROBE Statementhas been instituted 
for addressing three main study designs of analytical epidemiology: cohort, case-
control and cross-sectional studies. A checklist of 22 items was presented in order to 
improve the reporting quality of observational studies. The study design, details on 
recruitment of participants, study size, randomization, quantitative variables, main 
outcome, harms and especially potential funding all would be checked with the 
STROBE for quality assessment.  
1.3.4 Data Analysis 
Meta-analysis was performed with Cochrane’s Review Manager5.3(13)Mean 
Differences (MD) with 95% confidence intervals (CIs) of mortality were used to 
estimate differencesbetween people with dementia and people without dementia. 
Pooled mortality rate and 95% CIs were determined by using random effects model.  
I calculated 95% CI toestimate the variability around the mean mortality of each 
study group. The formula as following: 
 
Heterogeneity of included studies would be measured by I
2
 which can explain 
the percentage of the variability in effect due to heterogeneity. 
1.3.5 Results 
Study selection 
Flowchart of the selection process can be seen inFigure 1.1. Initially, a total 
of 1230 potential references were identified with the search strategy (294 through 
Medline, 830 through Embase, 95 through CINAHL, 1 through the Cochrane library 
and 10 through psycINFO)(Figure 1.1). Among the 1230 publications, 159 were 
duplicates(12.9%). 1046 articles were excluded based on the information provided by 
the titles and abstract mainly because some of them were found to be notrelated to 
my research. After that, there were 25 full textarticles screened. Among these 
articles, Sampson et al has published separately two articles in 2009 and 2013 with 
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almost the same study. I decided to include all of them and numbered them as ① a. 
and ① b. as they were believed not identical. Finally, 11 articles were excluded as8of 
them did not fulfil the inclusion criteria, 2 of them were conference abstracts and 1 of 
them was a Spanish journal with only English in the abstract. 
STROBE statement quality 
The result of applying the STROBE statement has been shown in Appendix1. 
We can see that almost every article has done well in title, abstract, introduction and 
discussion sections. Some of the items were not applicable such as 6B‘Matching for 
Participants’, 12D‘Sensitivity Analyses’, 16C‘Translating for the Main Result’or 
17‘Report Other Analyses Done’. Generally, we believed that these articles were 
reasonable quality although some were not applicable such as ‘Definition of 
Exposure’, ‘Potential Confounders’ and ‘Effect Modifiers’. 
Settings, methodology and characteristicsof papers 
The final 14 articles’ information ispresented inTable 1.1. Except for one 
paper that did not specify the study setting, the other 13 papers were all conducted 
within general hospitals. Among these 14 papers, 9 were prospective cohort study, 3 
were retrospective cohort study, and 2 were case control study and randomised 
control study respectively. Sample sizes differed greatly from each study. For 
retrospective cohort studies, the sample size would reach up to 3354017. However, 
for prospective cohort studies, sample size ranged from 250 to 794. Patients of 
studies also based on a numbers of countries (6 from UK, 2 from USA, one each 
from Spain, Germany, Australia, Netherland, Switzerland and China). In total, there 
were 8 papers mentioned screening for delirium. Most common screening tools for it 
were Confusion Assessment Method (CAM) (8), as 4 papers have used this method. 
10 papers have described dementia diagnosis, 4 of them used Diagnostic and 
Statistical Manual of Mental Disorders (DSM) (14). Besides, among 10 papers which 
had the cognition screen, the most prevalent method for diagnosis was Mini-mental 
State Examination (MMSE) (15).  
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Table 1.1Characteristic of 14 inclusionarticles 
Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools ①a 
Sampson 
et 
al.(16)(200
9) UK, 
British 
Journal of 
Psychiatry 
Medical 
acute 
admission
s unit 
Prospective 
cohort study 
Admitted<48h, did not 
speak sufficient 
English, admitted to 
surgical specialties, 
gynaecology, ear nose 
throat ophthalmology, 
cognitive impairment 
caused by delirium, 
delirium, discharged 
before assessment, 
refused consent 
>70 (83, 
no SD 
given) 
59 61
7 
CAM DSM-IV MMSE Functional 
Assessment, 
Stageing (FAST) 
Scale, Waterlow 
Scale, Charlson 
Co-Morbidity 
Scale, APACHE  
II, ICD-10 
           ①b 
Sampson 
et 
al.(17)(201
3) UK, 
Internation
al Journal 
of Geriatric 
Psychiatry 
General 
Hospital 
Prospective 
cohort study 
Admitted<48h, did not 
speak sufficient English 
>70 (83, 
no SD 
given) 
59 61
6 
CAM DSM-IV MMSE Waterlow Scale, 
ICD-10, Charlson 
comorbidity 
scale, APACHE II,  
Functional 
Assessment 
Staging Scale 
           ②Guijarro 
et 
al.(18)(201
0) Spain, 
Neuroepid
General 
hospitals 
Retrospectiv
e cohort 
study 
None >65 NA 33
54
07
1 
NO ICD-9-CM NO NO 
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Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools 
emiology ③
Whittamor
e et al.(19) 
(2014) UK, 
Internation
al Journal 
Of Geriatric 
Psychiatry 
Acute 
geriatric 
medical 
ward, 
trauma 
orthopae
dic ward, 
general 
medical 
ward 
Prospective 
cohort study 
Discharged prior to 
reasons approached, 
repeatedly unavailable, 
too ill to screen, 
already in a study, 
refuse screen, no 
English 
≥70 (84, 
no SD 
given) 
66 25
0 
DRS-R-
98, DSM-
IV 
Not specified MMSE Neuropsychiatri
c Inventory, 
Cornell Scale for 
Depression in 
Dementia, 
Modified Early 
Warning Score, 
Charlson Scale, 
Frailty index, 
Barthel Index 
           ④Kennedy 
et al.(20) 
(2014) UK, 
Journal of 
the 
American 
Geriatrics 
Society 
Urban 
tertiary 
care ED 
Prospective    
observation
alcohort 
study 
Non-English speaking, 
inability to provide 
informed consent, 
non-availability of a 
surrogate for informed 
consent, high acuity of 
illness 
≥65 (77, 
no SD 
given) 
51 70
0 
CAM NO  MMSE, 
Delirium 
Symptom 
Interview, 
Memorial 
Delirium 
Assessmen
t Scale, 
Attention 
test,  
 APACHE  II 
score 
           ⑤Eeles et 
al.(21) 
(2010) UK, 
Age and 
Ageing 
General 
medical 
service 
Prospective 
cohort study 
Unavailability of proxy 
consent 
≥75 
(82.5, 
5.6) 
NA 27
8 
DSM-IV NO IQCODE-
10, MMSE 
Greenfield 
Index, Charlson 
morbidity score, 
Barthel Index 
score 
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Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools ⑥Bickel et 
al.(22) 
(2006) 
Germany, 
Dementia 
and 
Geriatric 
Cognitive 
Disorders 
General 
hospital  
Prospective 
cohort study 
Very severe physical 
illness, complications 
were to be expected 
due to participation in 
the study, previously 
extant dementia, 
residence in a nursing 
home, the need for 
nursing care, blindness 
or deafness, 
inadequate facility in 
German, imminent 
release within 48 h 
Age 
between 
65 and 
85 (75.2, 
5.5) 
59.1 79
4 
NO DSM-III-R, DSM-
IV, ICD-10 
SIDAM Cambridge 
Examination for 
Mental 
Disorders of the 
Elderly, KUSTA, 
Comorbidity 
Index 
           ⑦Draper,B 
et al. (23) 
(2011) 
Australia, 
Internation
al 
Psychogeri
atric 
Admitted 
patient 
care 
database 
Retrospectiv
e cohort 
study 
NA >50 * NA 25
30
00 
ICD-10-
AM 
ICD-10-AM NO  
           ⑧
Buurman, 
B et al. 
(24)(2011) 
Netherland
, PLoSONE 
General 
internal 
medicine 
wards 
Prospective 
multicentre 
cohort study 
Did not provide 
informed consent, 
unable to speak or 
understand Dutch, 
came from another 
ward inside or outside 
65 
(78.2,7.8
) 
53.8 63
9 
CAM NO MMSE CGA, The 
Charlson co-
morbidity Index, 
ICD-9, IQCODE-
SF 
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Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools 
the hospital, transfer 
to the ICU, the 
Coronary Care Unit or 
another ward in or 
outside the hospital 
within 48 hours of 
admission, terminally 
ill 
           ⑨
Goldberg.S
E et al.(25)( 
2013) UK, 
BMJ(Online
) 
Acute 
medical 
admission 
unit  
Randomised 
control trial 
Patients with a clinical 
need for another 
specialist service 
>65 (85, 
no SD 
given) 
52 60
0 
DRS NO MMSE DEMQOL, 
EuroQoLED-
5D,short London 
handicap Scale, 
neuropsychiatric 
inventory, 
Barthel index, 
carer strain 
index, general 
health 
questionnaire, 
GHQ-12, carer's 
satisfaction, 
Likert Scales 
           ⑩
Dodson,J.A
. et al. 
(26)(2013) 
USA, 
Not 
specified 
Prospective 
cohort study 
Non-English speaking, 
admitted from a 
nursing home, had 
isolated right-side 
heart failure, were 
65 (80,8) 53.2 28
2 
NO NO MMSE NO 
12 
 
Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools 
American 
Journal of 
Medicine 
found to be delirious 
on the basis of the 
Confusion Assessment 
Method, being 
dependent in ≥3 
activities of daily living 
2 weeks before 
admission 
           ⑪
Joray,MD 
et al.(27) 
(2004) 
Switzerlan
d, The 
American 
Journal of 
Geriatric 
Psychiatry 
General 
internal-
medicine 
service 
Prospective  
cohort  
study 
Discharge within 24 
hours, previously living 
in a nursing home, 
transfer from another 
hospital for an elective 
procedure, had private 
insurance, unstable 
medical conditions, 
aphasia or stroke, 
terminal illness or 
coma, inability to give 
a correct name and 
date of birth  
≥75 
(82.4,5.0
) 
60.9 40
1 
NO NO MMSE ADL Scale, 
Lawton 
Instrumental 
ADL scale, GDS 
           ⑫Li Fang 
et al.(28) 
(2013) 
China, 
Aging AND 
Experiment
Departme
nt of 
Neurology 
Retrospectiv
e case-
control 
study 
Brain dysfunction due 
to psychiatric disease, 
drug abuse, severe 
neurologic impairment 
that affected 
completion of the 
≥60(75.8
2,7.42)(d
ementia) 
37.15(
demen
tia) 
34
88
8 
NO DSM-IV-TR, 
Statistical 
Manual of 
Mental 
Disorders, 
MMSE, NINCDS-
NO ICD-10, CIRS-G 
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Paper Setting Type of 
study 
Exclusion criteria Age 
range 
(mean, 
SD) 
Female 
% 
Sample 
size 
Delirium 
screen 
Dementia 
screen 
Cognition 
screen 
Other 
assessment 
tools 
al Research psychological 
evaluation or physical 
examination 
ADRDA, NINDS-
Airen, Hachinski 
Ischemic Scores 
           ⑬
Daiello,L.A 
et al. 
(29)(2014), 
USA, 
Archives 
and 
Gerontolog
y and 
Geriatrics 
Fee-for-
services 
Medicare 
administr
ative 
claims 
data 
Retrospectiv
e cohort 
study 
Less than 30 days of 
post-Discharge claims 
data available, the 
admission involved a 
same day transfer to or 
from another acute-
care hospital 
(81,11.7)
(dementi
a 
diagnosis
),(72.4,1
4.5)(not 
dementi
a) 
62.4(d
ementi
a),55.0
(not 
demen
tia) 
25
83
9 
NO ICD-9-CM NO NO 
APACHE II = Acute Physiology and Chronic Health 
Evaluation II;  
ADL = Activities of Daily Living;  
CAM = Confusion Assessment Method;  
CGA= Comprehensive Geriatric Assessment;  
CIRS-G= Cumulative Illness Rating Scale-Geriatric;  
DEMQOL= Dementia Quality of Life measure;  
DRS = Delirium Rating Scale;  
DSM = Diagnostic and Statistical Manual of Mental 
Disorders;  
ICD= International statistical classification of disease;  
GDS = Geriatric Depression Scale;  
GHQ= General Health Questionnaire; 
IQCODE = Informant Questionnaire on Cognitive Decline in 
the Elderly;  
MMSE = Mini-mental State Examination;  
SD = standard deviation;  
SIDAM= Kurz-SkalaStimmung/Aktivierung. 
*In Draper et al study, age range was >50, but the result was presented by age group. For our study, we just extracted the results from patients’ age>65. 
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Prevalence and mortality of patients with Dementia/ Delirium/ Cognitive 
Impairments 
There were 7 papers that described prevalence of dementia, with the range 
from 2.6% to 43%(Table 1.2). Only 4 papers explored prevalence of delirium, with 
the range from 9% to 43%. Half of the included papers studied the prevalence of 
cognitive impairments, with a range of 19% to 48.6%. 
Table 1.3describes mortality with dementia/delirium/cognitive impairments 
from each study. There were 6 studies assessing mortality of dementia in 30 days. 
Other papers also have description of mortality in 30 days, 6 months and 12 
months+, but this did not involve more than 3 papers. I decided there was little sense 
in doing such a comparison with a small number of papers. It is also difficult in terms 
of heterogeneity. Finally, Idecided to conduct a Meta-analysis with papersthat study 
dementia and 30 days’ mortality. Meta- analysis of 6 papers showed that people with 
dementia had significantly greater mortality by 11% (95%CI: 6%-16%, p<0.001, see 
Forest plot in Figure 1.2), compared with people without dementia, with significant 
heterogeneity (I
2
= 68%, p= 0.01). 
 There were 6 studies examined for the length of hospital stay for 
dementia/delirium/cognitive impairment students (Table 1.4). The longest stay was 
26.1 days; the minimum length was 4.6 days. There were a totalof 5 studies with 
rehospitalisation rate of 30 days (27% and 17.8%), 6 months after admission (40%) 
and 12months after admission (59%). 
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Table 1.2Prevalence ofdelirium/dementia/cognitive impairment for patients aged 65+ in general hospital 
Paper Delirium % 
(95% CI), N 
Dementia % (95% CI),N Cognitive impairment % 
(95% CI),N ①a. Sampson et al.(2009) UK, British Journal of Psychiatry NA 42.4(38.5-46.3),261 47.9(43.96-51.84),296 
    ①b. Sampson et al.(2013) UK, International Journal of 
Geriatric Psychiatry 
NA 42.4(38.5-46.3),262 47.9(43.95,51.85),296 
    ②Guijarro et al.(2010) Spain, Neuroepidemiology NA 3.43→4.64 (from 1998 to 2003)(3.41-3.45→ 
4.62-4.66), 5245→8209 
NA 
    ③Whittamore et al. (2014) UK, International Journal Of 
Geriatric Psychiatry 
43(36.9-
49.1),107 
43(36.85-49.15),106 48.6(42.39-54.81),121 
    ④Kennedy et al. (2014) UK, Journal of the American 
Geriatrics Society 
9(6.9-11.1),63 NA NA 
    ⑤Eeles et al. (2010) UK, Age and Ageing 37.1(31.4-
42.8),103 
NA NA 
    ⑥Bickel et al. (2006) Germany, Dementia and Geriatric 
Cognitive Disorders 
NA NA 36.1(32.76-39.44),287 
    ⑦Draper,B et al.  (2011) Australia, International 
Psychogeriatric 
NA 8(7.89-8.11),20034 NA 
    ⑧Buurman, B et al. (2011) Netherland, PLoSONE 40.1(36.3-
43.9),256 
NA 19(15.96-22.04),118 
    
16 
 
Paper Delirium % 
(95% CI), N 
Dementia % (95% CI),N Cognitive impairment % 
(95% CI),N 
 ⑨Dodson,J.A. et al. (2013) USA, American Journal of 
Medicine 
 
NA 
 
NA 
 
46.8(40.98-52.62),132 
    ⑩Joray,MD et al. (2004) Switzerland, The American 
Journal of Geriatric Psychiatry 
NA NA 32.3(27.72-36.88),129 ⑪Li Fang et al. (2013) China, Aging AND Experimental 
Research 
NA 2.6(2.43-2.77),918 NA 
    ⑫Daiello,L.A et al. (2014), USA, Archives and Gerontology 
and Geriatrics 
NA 15.1(14.66-15.54),3908 NA 
    ⑬Goldberg.SE et al. 2013 UK, BMJ(Online)RCT NA NA NA 
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Table 1.3 Mortality of delirium/dementia/cognitive impairment for patients aged 65+ in general hospital 
Confusion 
Condition 
Paper Mortality % (95%CI),N 
 
 30 Days(Index 
admission) 
6 Months 12 Months+ ①a.Sampson et al.(2009) UK, British Journal of Psychiatry 18.1(15.06-33.16),47  NA NA 
 
   ①b.Sampson et al.(2013) UK, International Journal of 
Geriatric Psychiatry 
15(12.18-27.18),39  39.1 (33.1-45.0),102 48.3(42.2-54.4),126  
 
   ②Guijarro et al.(2010) Spain, Neuroepidemiology 19.3(19.26-38.56), 
7813 
NA NA 
 
   
Dementia 
⑦Draper,B et al.  (2011) Australia, International 
Psychogeriatric 
8.3(8.19-16.49),3160  NA NA 
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Confusion 
Condition 
Paper Mortality % (95%CI),N 
 
 30 Days(Index 
admission) 
6 Months 12 Months+ 
 
   ⑪Li Fang et al. (2013) China, Aging AND Experimental 
Research 
9.8(9.49-19.29),90  NA 34.3(33.80-34.80),315  
 
   ⑫Daiello,L.A et al. (2014), USA, Archives and Gerontology 
and Geriatrics 
8(7.67-15.67),313  NA NA 
  
   ③Whittamore et al. (2014) UK, International Journal Of 
Geriatric Psychiatry 
NA 37(31.00-43.00),40  NA 
 
   
Delirium 
④Kennedy et al. (2014) UK, Journal of the American 
Geriatrics Society 
6(4.23-10.23),4  NA NA 
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Confusion 
Condition 
Paper Mortality % (95%CI),N 
 
 30 Days(Index 
admission) 
6 Months 12 Months+ 
 
   ⑤Eeles et al. (2010) UK, Age and Ageing 35.9(30.26-66.16),37  NA NA 
     
Cognitive 
Impairment 
①a.Sampson et al.(2009) UK, British Journal of Psychiatry 17.22(14.24-31.46),51  NA NA 
 
 
   
 
Cognitive 
Impairment  ①b.Sampson et al.(2013) UK, International Journal of 
Geriatric Psychiatry 
 
NA 
 
37.5(33.68-41.32),132  
 
45.7(41.77-49.63),161  
  
   
 
⑩Joray,MD et al. (2004) Switzerland, The American Journal 
of Geriatric Psychiatry 
 7(4.50-11.50),9  28.7(24.27-33.13),37  NA 
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Confusion 
Condition 
Paper Mortality % (95%CI),N 
 
 30 Days(Index 
admission) 
6 Months 12 Months+ 
  
   
 
⑬Goldberg.SE et al. 2013 UK, BMJ(Online)RCT NA 25(21.5-28.46),71  NA 
 
 
 
Figure 1.2Forest plot of mortality compared with dementia and no dementia.
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Table 1.4 Hospital stay days and rehospitalisation rate for patients with dementia / 
delirium / cognitive impairment 
Paper Hospital stay days Rehospitalisation rate% ①a. Sampson et al.(2009) UK, British 
Journal of Psychiatry 
16.7 NA 
   ①b. Sampson et al.(2013) UK, 
International Journal of Geriatric 
Psychiatry 
16.7 NA 
   ②Guijarro et al.(2010) Spain, 
Neuroepidemiology 
13.4 NA 
   ③Whittamore et al. (2014) UK, 
International Journal Of Geriatric 
Psychiatry 
16 45 ( 6 months) 
   ④Kennedy et al. (2014) UK, Journal 
of the American Geriatrics Society 
4.6 27 (30 days) 
   ⑤Eeles et al. (2010) UK, Age and 
Ageing 
26.1 NA 
   ⑥Bickel et al. (2006) Germany, 
Dementia and Geriatric Cognitive 
Disorders 
20 (for the whole sample) NA 
   ⑦Draper,B et al.  (2011) Australia, 
International Psychogeriatric 
16.5 40(3 months) 
   ⑧Buurman, B et al. (2011) 
Netherland, PLoSONE 
NA NA 
   ⑨Dodson,J.A. et al. (2013) USA, 
American Journal of Medicine 
11 NA 
   ⑩Joray,MD et al. (2004) Switzerland, 
The American Journal of Geriatric 
Psychiatry 
NA NA 
   ⑪Li Fang et al. (2013) China, Aging 
AND Experimental Research 
9 37.4(undetected 
impairment), 41.7(detected 
impairment)(no specified 
time) 
   ⑫Daiello,L.A et al. (2014), USA, 
Archives and Gerontology and 
Geriatrics 
13 NA 
   ⑬Goldberg.SE et al. 2013 UK, 6.7 17.8(30 days) 
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BMJ(Online) 
1.3.6 Discussion 
Prevalence of confusion status 
The studies in the reviewhave coveredpatients across 6 countries, including 
Europe, North America, Australia and Asia. So the results can be seen as 
representing the general condition of confusion for the elderlyworldwide. The lowest 
prevalence of delirium was reported by Kennedy et al (20), with just 9%. His study 
was a prospective observational cohort study conducted in urban tertiary care 
emergency department(ED). The highest prevalence of delirium was 43% which was 
reported byWhittamore et al.(19). This study was conducted in an acute geriatric 
medical ward, trauma orthopaedic ward and general medical ward, with the 
population older and more female, which may cause the prevalence of dementia to be 
higher than other papers. In addition, they usedDRS-R-98 as tools to diagnosis 
delirium. Compared to other scales, DRS-R-98 were more sensitive (91% to100%) to 
differentiate delirium from dementia and depression and usually can be taken over a 
period(30, 31).The high sensitivity of the DRS-R-98 may cause the risk of making a 
false positive diagnosis, which may cause the high prevalence of this study(32). The 
lowest prevalence for dementia was reported as 2.6%. This study was a case-control 
study conducted over 10 years withina Neurology department of a tertiary hospital 
setting. The highest prevalence of dementia was reported by Sampson et al. (16), 
whose study was conducted among patients much older (>70 years old). Also the 
patients with delirium were excluded during the sample selection, which may cause 
the population so focused, to lead to a high prevalence. 
The measurement tools of the studies 
Each investigator of the studies must use some tools to avoid the 
misclassification between one confusion status and another.  Hardly any study 
explored dementia, cognitive impairment nor delirium all together. That maybe 
because of the difficulties in defining three confusion states clearly during diagnosis. 
Since each study had different background setting, various instruments had been used 
for assessing different confusion states. The most prevalent tools used among these 
studies to explore delirium was CAM(33), which is believed to have high specificity, 
accurate, concise and easy to  conduct by clinicians(31).The tools which were used to 
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screen for dementia varied among the included articles.DSM(14) was the most 
common one; ICD (34)was also used by some papers for dementia diagnosis. The 
MMSE was the most common tools used for assessing CI, accounting for 90% of the 
papers which have screening CI. This result was almost the same as a survey of 
assessment scales in Old Age Psychiatry services in England and Northern 
Ireland(35). In that survey, approximately 95% of the responds used the MMSE 
(15)as the cognitive screening instruments. 
Outcomes of the study 
The mortality of each kind of confusion state was only reported by one or 
more studies, still fewer that reported 30 days’ mortality, 6 months’ mortality and 12 
month’ mortality. So it was difficult to make general conclusions with all the 
individual forms of confusion state. I can just drawconclusions from the Meta-
analysis result of 30 days’ mortality which was that the 30 days’ mortality of people 
with dementia indeed had higher mortality than people with no dementia. As many 
studies did not report the outcome (length of stay, readmission rate etc.)for those 
with no confusion,Meta-analysis wasdifficultto be conducted with these outcomes. In 
Kennedy’s (20)paper, length of stay days was apparently shorter than other papers. 
Since the patients who admitted to tertiary hospital’s ED may be in much more 
serious condition than others in general hospital, and was more likely to discharge 
quickly to an intensive care facility.  
Limitations 
This systematic review may be limited by the small number of identified 
studies and its inclusion of articles printed only in English. As many included papers 
did not report the outcomes for people with no confusion, comparison and conclusion 
are difficult to make. Besides, this review was only conducted by 2 researchers, 
which may cause biases in selection and evaluation of the papers. Although the 
settings of the inclusion papers had been limited to general hospitals, the settings and 
admitted patients may be varied among community and countriesand heterogeneity 
measured by I squared was high. So the conclusion may make more sense when all 
the diversityis taken into account. As I include both the Sampson’s paper in, which 
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may mix some factors which may influence the results. Some papers used tools to 
select the patients with single condition. This may reduce the representativeness of 
the results. More compatible quality assessment tool should be adopted within the 
systematic review. 
1.3.7 Future Work 
If meta-analysis were doing again in retrospect, we might have only included 
one of these papers. However, for this project we would not do this again. To 
understand more about the relationship of final outcomes and confusion status of the 
patients, I conducted a data analysis with a dataset derived from a routine programme 
in a general hospital in Fife. This dataset will cover the whole population of Fife, 
which would bemore representative. In addition to the description of people’s 
characteristics, I will also conduct survival analysis for all-cause mortalitycontrolled 
by adjusting for many factors (demographic factors, social factors and co-morbidity) 
using Cox’s regression model . In addition, as two kinds of the most prevalent causes 
of death among the elderly,the relationship between cardiovascular / respiratory 
death and confusion status will be explored together in my later analysis. The 
assumption of proportional hazards in these models will also be explored. 
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2. Methods 
2.1 Setting 
The population is derived from Fife NHS Health Board on the east coast of 
Scotland. It is located between the Firth of Tay and the Forth, which is divided into 
three districts, Dunfermline, Kirkcaldy and North-East Fife(36). The region map can 
be seen from Appendix 2.Fife is the third largest local authority area of Scotland by 
population of just under 367,000. There are two main hospitals in Fife, Victoria 
Hospital in Kirkcaldy and Queen Margaret Hospital in Dunfermline (37).  As the 
main data sources for the study, the Victoria Hospital in Kirkcaldy was opened in 
January 2012 and housed all emergency admissions in NHS Fife.  
2.2 Dataset and Participants 
The data comes from the Cognitive Geriatric Assessment research (CGA) 
programme, which was a retrospective cohort study conducted with Older Persons 
Acute Assessment (OPRAA) dataset which already existed.  From 2009, NHS Fife 
has performed a pilot project to evaluate the impact of standardised Acute 
Comprehensive Geriatric Assessment (A-CGA) among patients over 65 years who 
were admitted into the Victoria Hospital.  Over time, the A-CGA obtained a positive 
feedback from the patients’ families and carers. It has also been noticed that the 
identification of undiagnosed dementia has increased. As a result, NHS Fife decided 
to adopt OPRAA which was designed based on A-CGA as a routine clinical 
identification from April 2011. One questionnaire was used to investigate the 
patients’ functional and cognitive ability, screen for delirium, and document their 
socio-environmental situation.  Patients aged above 65 years’ old who have an 
admission to acute hospital (except patients with a predicted length of stay less than 
24 hours, a poor prognosis or acute illness) are required to take OPRAA by trained 
specialist nurses. All the results of assessment are recorded electronically which can 
be uploaded and are curated by the Health Informatics Centre (HIC) in Dundee 
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University(38). Before the analysis, all the dataset has been cleared by one 
statistician for the feasibility of the analysis. 
The OPRAA dataset currently holds over 13000 admission records and is 
being updated every week. The routine assessment questionnaire can be seen from 
Appendix 3. Apart from Fife OPRAA dataset, the CGA program also took advantage 
of other datasets hosted by HIC for analysis; such as the general registrar office 
(GRO) death dataset, the Scottish Morbidity Records 01(SMR01) dataset and the 
patient-level community dispensed prescribing dataset.  
For this study, the group of interest was the OPRAA records of patients aged 
65 years or more who were admitted to Fife Victoria hospital between 01 January 
2012 and 31 December 2012. If more than one visit was recorded, the first admission 
was used. These participants’ data were followed up until 30 September 2013. So the 
maximum follow up length would be 21 months. In addition, we also linked the 
SMR01 dataset, GRO dataset and the master Community Health Index (CHI) dataset 
held by HIC (38)for analysis. The group for control in the statistical models would be 
the patients who also admitted in Victoria hospital but did not have the confusion 
problems. 
• SMR01 data will also be used to calculate Charlson Comorbidity Index (CCI) 
(39-43). 
• GRO data will be used to obtain the participant’s death data and to calculate 
survival time within the follow-up period, and to obtain the causes of death. 
• Anonymised CHI(ProCHI) data will be used to get patient’s demographic 
details including age, sex, Scottish Index of Multiple Deprivation score 
(SIMD)(44) . 
2.3 Covariates and Definitions 
Pro-CHI 
The Pro-CHI is generated by the HIC Data Analyst to uniquely anonymise a 
typical NHS dataset with the standard patient-identifiable CHI number. There are 
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also 10 digits for the Pro-CHI. The first 3 digits are character and the last 7 are 
integers. 
Dementia 
Dementia in OPRAA referred to diagnosis which was done by specialist 
memory clinics who are in charge of initiating drugs to treat dementia. In other 
words, diagnosed dementia participants were people who had a pre-admission 
diagnosis record or received any licenced drug for the treatment of dementia.Those 
with no such record on admission to Victoria hospital were coded as zero for no 
dementia.  
General clinical delirium 
Admissions with accompanying drowsiness with a change from usual 
function or activity can be treated as general clinical delirium. In addition, clinical 
history suggestive of delirium also would be classified into general clinical 
delirium.Those patients who were also admitted in the same hospital but without 
drowsiness or a clinical delirium history would be coded as zero for no general 
clinical delirium. 
Fully syndromic delirium (FSD) 
The lack of uniform diagnostic criteria and frequently presented nonspecific 
delirium among the elderly has resulted in poor clinical management and study of 
delirium. Delirium is often overlooked or misdiagnosed as depression or psychosis, 
as in one study, only 35% of delirium cases were truly recognized by physicians(45). 
Considering the complexity and difficulty of a diagnosis of delirium, the Confusion 
Assessment Method (CAM) score was specified and used to define the fully 
syndromic delirium(33).The CAM includes two parts. Part one is an assessment 
instrument which contains 9 questions to evaluate overall cognitive impairment. Part 
two includes four distinguishing features which can apparently identify delirium or 
reversible confusion from other types of cognitive impairment. The diagnosis of 
delirium required the presence of both first and second features and of either the third 
or the fourth feature. FSD is a more definitive diagnosis of delirium than general 
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clinical delirium.Those patients who were also admitted to the Victoria hospital but 
were negative to the CAM assessment were coded as zero for no FSD. 
Cognitive impairment (CI) 
The population with cognitive impairment was defined as having Abbreviated 
Mental Test (AMT) score of 7 or less on admission(46, 47). With ten questions, the 
AMT was first introduced in 1972, which is probably the most well-known test in 
general hospital use. Those patients who were also admitted to the Victoria 
hospitalwith the AMT score above 7 were defined as having no CI. 
CCI 
The CCI is the most commonly used score to summarise comorbidity for 
patients according to the International Classification of Disease, 10th Revision (ICD-
10) (34). Adjusting for risk of mortality or resource use, each kind of comorbidity 
has different score weight. The CCI is the sum of all the weights of a patient. For 
example, a score of zero means there is no comorbidity found for the patient. With 
the CCI increasing, the risk of death will also increase or more resource will be 
used(39). In this study, the original CCI has been recoded into 4 categories: score 0, 
score 1-2, score 3-4, and score 5+. 
The cause of death 
The international statistical classification of disease and related health 
problems 10
th
 revision (ICD-10)(34) were used for classification of cause of death. 
ICD records of J00-J99 were diagnosis of disease of the respiratory system 
(Respiratory) and I00-I99 were diagnosis of disease of the circulatory system (CVD). 
In this study, only these two causes of mortality were explored in addition to all-
cause mortality. 
Demography 
The demographic variables included gender, age and SIMD.SIMD is the 
Scottish Government's official tool for identifying those places in Scotland suffering 
from deprivation(44). It incorporates seven different domains of deprivation 
(Employment; Income; Health; Education, Skills and Training; Geographic Access to 
Services; Crime; Housing), combining them into a single index. SIMD has divided 
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Scotland into 6,505 small areas, called data zones, each containing around 350 
households. The Index provides a relative ranking for each data zone, from 1 (most 
deprived) to 5 (least deprived). For my analysis, I looked the SIMD with ranks to 
quintiles, which splits the data zones into 5 groups, each containing 20% of the 
whole Scotland’s data zones (Table 2.1). The local SIMD summary for Fife 
published in 2012 can be seen from theAppendix4. 
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Table 2.1SIMD ranks to quintiles 
SIMD Rank 
Quintile (20%) From To 
1 1 1301 
2 1302 2602 
3 2603 3903 
4 3904 5204 
5 5205 6505 
 
2.4 Outcomes 
The main outcome of the study was the survival time for all-cause mortality 
of each patient. Survival time was the result of the patient’s registered death date 
subtracted from the admission date. For the patients who were still alive until the end 
date of the follow-up; I censored them at 30 September 2013 to subtract admission 
date to get a censored survival time for analysis. 
2.5 Data Management and Ethics 
The data for study was all supported by Health Informatics Centre (HIC) 
Services(38), which is a University of Dundee research support unit within Tayside 
Academic Science Collaboration (TASC) and the Farr Institute, in collaboration with 
NHS Tayside and NHS Fife. HIC Services supports high impact research through the 
collection and management of high quality data. The environment which HIC 
Services provides is within a “Safe Haven”, which has strong governance for the 
provisioning of data to academics and other users. In this model, data are not released 
externally to data users for analysis on their own computers but placed on a server at 
HIC, within a restricted and secure IT environment. 
The Community Health Index (CHI) is a unique population register number 
which was generally used in NHS(48). To maximise data security and data subject 
confidentiality, HIC anonymises the data used for research using a project specific 
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anonymised Pro-CHI. Each Pro-CHI is generated by the HIC Data Analyst to 
uniquely anonymise a typical NHS dataset CHI number(38). 
The datasets which analysed for this study were complete datasets after 
cleaning, which hopefully represented 80% of all the potential admissions. 
Research use was with the consent of the NHS Fife Caldicott Guardian based 
on researcher access only to anonymised data in a secure Safe Haven that does not 
permit data export. The dataset will be linked subject to HIC Standard Operating 
Procedures, which have been reviewed by the NHS Tayside Research Ethics Service.  
2.6 Data Analysis 
The data were analysed by four age groups: 66-75 years; 76-85 years; 86-95 
years; and 96 years and over. The analyses were conducted using SAS version9.3 
provided by the server of the Safe Haven of HIC. Descriptive analyses of patients’ 
characteristics were described in terms of frequencies, percentages for categorical 
variables, means and standard deviations (SD) for continuous variables. 
Characteristic differences across the people with dementia and no dementia, CI and 
no CI, clinical delirium and no clinical delirium, FSD and no FSD were checked for 
significance using  tests and ANOVA tests. In order to describe the distribution of 
survival times and test differences in survival between different age groups, gender, 
CCI,SIMD and disease groups, Kaplan-Meier procedures and Log-Rank Tests were 
conducted. The starting point was a specific admission date between 01 January 2012 
to 31 December 2012, and the end of the follow-up period was 30 September 2013. 
The event of interest was all-cause death. Survival times of patients who were still 
alive were censored at the end of the follow-up time on 30 September 2013. The 
median survival time and 95% confidence intervals (95% CIs) would be used to 
summarise the distribution of survival times. The median survival time is stated as 
the time half of the patients are expected to survive. Log-Rank tests with a result of 
p<0.05 illustrated the significance of differences in survival time between the groups. 
Cox’s proportional hazards regression model was also employed to investigate the 
association between death and survival time with multiple predictors. Backward 
elimination method was used for modelling adjusted age group, gender, SIMD, CCI 
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and variables of cognition status. To check the validity of the survival model, 
Kolmogorov-Type Supremum Tests (49)with the ‘assess’ statements in SAS were 
also added in the final model. The ‘assess’ statement used the graphical and 
numerical method for checking the adequacy of the Cox regression model. This 
method is derived from cumulative sums of martingale residuals over follow-up 
times or covariate values. The results of p>0.05 for this test would represent the 
assumption of proportional hazards was satisfactory in the established model. Cox’s 
model and Kaplan-Meier plots were also employed to check the relationship between 
Respiratory and CVD mortality and the four variables of cognition status adjusted for 
other factors. Some of the key SAS code for the study can be seen from Appendix5. 
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3. Results 
3.1 Characteristics of Patients 
During the follow-up period, there were a total of 4780 patients with age 65+ 
years on admission.  Characteristics of these patients are shown inTable 3.1. The 
mean age was 81.5 years with a standard deviation of 8.0 and 56% (2678) of patients 
were female. The median survival time was 355 days. According to the records, 
clinical delirium and CI were the two most prevalent diagnoses, with 22.8% (1089) 
and 16.7% (796) respectively. Only less than 10% of patients were diagnosed as 
having dementia or FSD respectively (8.6%, 413 for dementia; 6.6%, 317 for FSD). 
23.6 %(1127) of the patients were found tocomefrom the most deprived postcode 
sectors in Scotland. Over 50 %(50.8%, 2429) of patients have a CCI between 1 and2. 
The all-cause mortality was 34.4 %( 1643), among the patients who have died, 6% 
(288) of them dieddue to respiratory condition and 9.2% (441) as a result of CVD. 
Table 3.2and Table 3.3indicates the results of bivariate comparisons between 
each specified confusion condition group and no condition cases. Each condition 
group wasfrom an older population (means 86.2 versus 81.0 for dementia; 83.7versus 
80.8 for clinical delirium; 85.3 versus 81.2 for FSD; 85.4 versus 80.7 for CI; p<0.01 
for differences). Females accounted for a higher percentage for each condition group 
(64.4% for dementia; 57.3% for clinical delirium; 60.3% for FSD; 60.8% for CI), 
even though the gender difference between clinical delirium /CI and no delirium /CI 
group was not statistically significant. CCI was found to significantly differ between 
people with the condition and no condition group except for FSD (p<0.05), with 
most of the population score 1 to 2 in CCI for every group. Apart from dementia, the 
other three condition groups all have significant differences in distribution of 
mortality from CVD compared with the no condition population (p<0.05 for 
differences).  
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Table 3.1Baseline characteristics of the total population 
 Total  population (N=4780) 
Age, years, mean± SD 81.5±8.0 
  
Female,%(N) 56(2678) 
  
Dementia,%(N) 8.6(413) 
  
Clinical delirium,%(N) 22.8(1089) 
  
FSD,%(N) 6.6(317) 
  
CI,%(N) 16.7(796) 
  
0-20% Most deprived 23.6(1127) 
20-40% 27.8(1330) 
40-60% 23.2(1108) 
60-80% 13.8(659) 
SIMD,%(N)* 
80-100% Least deprived 11.6(554) 
   
0 26.8(1283) 
1-2 50.8(2429) 
3-4 14.8(709) 
CCI,%(N) 
5+ 7.5(359) 
   
Survival time, days, median± SD 355±185.8 
  
All-cause mortality,%(N) 34.4(1643) 
  
Respiratory mortality,%(N) 6.0(288) 
  
CVD co-mortality,%(N) 9.2(441) 
 
SD: standard deviation;  
FSD: Fully syndromic delirium;  
CI: Cognitive impairment;  
SIMD: Scottish Index of Multiple Deprivation score;  
CCI: Charlson Comorbidity Index;  
RESP: Disease of the respiratory system;  
CVD: Disease of the circulatory system. 
* SIMD data missing for 2 patients. 
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Table 3.2Characteristics of the patients with dementia/CI and bivariate comparisons 
between disease groups 
 Dementia CI 
 Yes 
N=413 
No 
N=4367 
P* Yes 
N=796 
No 
N=3984 
P* 
Age, years 
mean± SD 
86.2±6.7 81.0±8.0 <0.01 85.4±7.3 80.7±7.9 <0.01 
       
Female,% 
(N) 
64.4 
(266) 
55.2 
(2412) 
<0.01 60.8 
(484) 
55 
(2194) 
<0.01 
 
       
Rank   0.52   0.04 
0-20% Most deprived 20.1 
(83) 
24 
(1044) 
 27.5 
(219) 
22.8 
(908) 
 
20-40% 28.6 
(118) 
27.8 
(1212) 
 27.4 
(218) 
28 
(1112) 
 
40-60% 24 
(99) 
23.1 
(1009) 
 22.1 
(176) 
23.4 
(932) 
 
60-80% 14.8 
(61) 
13.7 
(598) 
 11.7 
(93) 
14.2 
(566) 
 
SIMD,% 
(N)** 
80-100% Least deprived 12.6 
(52) 
11.5 
(502) 
 11.3 
(90) 
11.7 
(464) 
 
       
Rank   <0.01   0.07 
0 7.3 
(30) 
28.7 
(1253) 
 25.1 
(200) 
27.2 
(1083) 
 
1-2 69.0 
(285) 
49.1 
(2144) 
 51.3 
(408) 
50.7 
(2021) 
 
3-4 21.6 
(89) 
14.2 
(620) 
 17.3 
(138) 
14.3 
(571) 
 
 
CCI,% 
(N) 
5+ 2.2 
(9) 
8.0 
(350) 
 6.3 
(50) 
7.8 
(309) 
 
       
Respiratory co-mortality, % 
(N) 
7.5 
(31) 
5.9 
(257) 
0.19 6.4 
(51) 
6.0 
(237) 
0.62 
 
       
CVD co-mortality, % 
(N) 
11.1 
(46) 
9.1 
(395) 
0.16 13.3 
(106) 
8.4 
(335) 
<0.01 
 
SD: standard deviation;  
FSD: Fully syndromic delirium;  
CI: Cognitive impairment;  
SIMD: Scottish Index of Multiple Deprivation score;  
CCI: Charlson Comorbidity Index;  
CVD: Disease of the circulatory system. 
*   Chi-square test (for categorical variables) or ANOVA (for continuous variables) comparing subjects 
with dementia to no dementia; CI to no CI. 
** SIMD data missing for 2 patients.
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Table 3.3Characteristics of the patients with clinical delirium/FSD and bivariate 
comparisons between disease groups 
 Clinical delirium FSD 
 Yes 
N=1089 
No 
N=3691 
P* Yes 
N=317 
No 
N=4463 
P* 
Age, years 
mean± SD 
83.7±7.6 80.8±8.0 <0.01 85.3±7.0 81.2±8.0 <0.01 
       
Female,% 
(N) 
57.3 
(624) 
55.7 
(2054) 
0.33 60.3 
(191) 
55.7 
(2054) 
0.12 
       
Rank   0.94   0.43 
0-20,% 
Most 
deprived 
23.4 
(254) 
23.7 
(873) 
 22.1 
(70) 
23.7 
(1057) 
 
20-40% 23.2 
(309) 
27.7 
(1021) 
 26.8 
(85) 
28 
(1245) 
 
40-60% 23.3 
(253) 
23.2 
(855) 
 25.9 
(82) 
23 
(1026) 
 
60-80% 14.1 
(153) 
13.7 
(506) 
 15.8 
(50) 
13.7 
(609) 
 
SIMD,% 
(N)** 
80-100% 
Least 
deprived 
11 
(119) 
11.8 
(435) 
 9.5 
(30) 
11.8 
(524) 
 
       
Rank   <0.01   0.56 
0 23.3 
(254) 
27.9 
(1029) 
 28.7 
(91) 
26.7 
(192) 
 
1-2 52.0 
(566) 
50.5 
(1863) 
 47 
(149) 
51.1 
(2280) 
 
3-4 18.0 
(196) 
13.9 
(513) 
 16.4 
(52) 
14.7 
(657) 
 
CCI,% 
(N) 
5+ 6.7 
(73) 
7.8 
(286) 
 7.9 
(25) 
7.5 
(334) 
 
       
Respiratory co-
mortality,% 
(N) 
7.3 
(79) 
5.7 
(209) 
0.05 7.3 
(23) 
6.0 
(265) 
0.34 
       
CVD co-
mortality,% 
(N) 
13.4 
(146) 
8.0 
(295) 
<0.01 14.5 
(46) 
8.9 
(395) 
<0.01 
 
SD: standard deviation;  
FSD: Fully syndromic delirium;  
CI: Cognitive impairment;  
SIMD: Scottish Index of Multiple Deprivation 
score;  
CCI: Charlson Comorbidity Index;  
CVD: Disease of the circulatory system. 
*   Chi-square test (for categorical variables) or ANOVA (for continuous variables) comparing subjects 
with clinical delirium to no clinical delirium; FSD to no FSD. 
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** SIMD data missing for 2 patients.
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3.2 Analysis of Median Survival Time and Kaplan-Meier 
Survival Curves 
In total, there were 1643 patients who died between 01 January 2012 and 30 
September 2013.Among the cases, there were always over 40% mortality no matter 
which condition group the patients belonged to. Log-Rank tests highlighted that there 
were significant differences of  mortality between age group, gender, CCI and four 
condition groups (p ≤0.01) (Table 3.4).However, the mortality was shown to be 
similar with different SIMD groups. Median survival time can only be observed with 
age group 95+ (345 days), dementia group (544 days), FSD group (541days) and 
CCI 5+ group (61 days). 
Table 3.4Log-Rank test and median survival time for the patients dead with all-cause 
  Median survival time, 
days(95%CI) 
Death,%(N) Log-Rank  
P-value 
66-75 NA 25.4(319) <0.01 
76-85 NA 23.1(641)  
86-95 NA 42(602)  
Age group 
95+ 345(210,NA) 52.3(81)  
     
Male NA 37.2(862) <0.01 Gender 
Female NA 32.2(781)  
     
Yes 544(455,NA) 45(186) <0.01 Dementia 
No NA 33.4(1457)  
     
Yes NA 42(457) <0.01 Clinical 
delirium No NA 32.1(1186)  
     
Yes 541(363,NA) 48(152) <0.01 FSD 
No NA 33.4(1491)  
     
Yes NA 43.2(344) <0.01 CI 
No NA 32.6(1299)  
     
0 NA 21.9(281) <0.01 
1-2 NA 31.5(766)  
3-4 NA 43(305)  
CCI 
5+ 61(50,78) 17.7(291)  
     
0-20% Most deprived NA 33.3(375) 0.43 
20-40% NA 34.7(462)  
SIMD* 
40-60% NA 36(399)  
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  Median survival time, 
days(95%CI) 
Death,%(N) Log-Rank  
P-value 
60-80% NA 34.9(230)  
80-100%Least deprived NA 31.8(176)  
* SIMD data missing for 2 patients 
Graphical assessment of survival probability between groups and other 
patients using the Kaplan-Meier survival curves can be seen from Figure 3.1 toFigure 
3.8. The differences mentioned above remained in the curves. Even though some of 
the median survival times were not available from the previous analysis , four 
survival curves(Figure 3.1-Figure 3.4) all illustrates that no condition group always 
had a better survival probability in terms of survival days than the condition group, 
also with a significant trend for agegroup (Figure 3.5). Figure 3.6and Figure 
3.7indicates that either patients with more comorbidity or male patientshave poorer 
survival than patients with less comorbidity or female. The mortality of those 
patients with different SIMD differed slightly, but these differences were not 
significant, which can also be observed from Figure 3.8.  
 
Figure 3.1Kaplan-Meier survival Curves of all-cause mortality for patients with and 
without dementia (0: no dementia; 1: dementia). 
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Figure 3.2Kaplan-Meier survival Curves of all-cause mortality for patients with and 
without clinical delirium (0: no clinical delirium; 1: clinical delirium). 
 
Figure 3.3Kaplan-Meier survival Curves of all-cause mortality for patients with and 
without FSD (0: no FSD; 1: FSD). 
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Figure 3.4Kaplan-Meier survival Curves of all-cause mortality for patients with and 
without CI (0: no CI; 1: CI). 
 
Figure 3.5Kaplan-Meier survival Curves of all-cause mortality for patients with 
different age groups (1:66-75 years old; 2: 76-85 years old; 3:86-95 years old; 4: 95+ 
years old). 
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Figure 3.6Kaplan-Meier survival Curves of all-cause mortality for patients with 
different CCI groups (1: score0; 2: score1-2; 3: score3-4; 4: score5+). 
 
Figure 3.7Kaplan-Meier survival Curves of all-cause mortality for patients with each 
gender. 
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Figure 3.8Kaplan-Meier survival Curves of all-cause mortality for patients with 
different SIMD (1: most deprived; 2: 20-40% deprived; 3: 40-60% deprived; 4: 60-
80% deprived; 5: 80-100% least deprived). 
3.3 Mortality for 30 Days, 6 Months and 12Months 
There were no large differences between mortality for people with and 
without each condition (Table 3.5). Compared with no condition, each type of 
condition had significantly higher 6 months’ mortality (p<0.01). The maximum 
difference was seen with FSD and no FSD, which reached up to 11.5%. There were 
no significant differences between dementia and no dementia in 30 days’ and 12 
months’ mortality, even though the mortality was indeed higher for dementias. 
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Table 3.5Comparison tables of 30 days, 6 months and 12 months mortality for 
confusion patients with no confusion patients 
 30 days’ 
mortality %(N) 
P* 6 months’ 
mortality %(N) 
P* 12 months’ 
mortality %(N) 
P* 
13.3(55) 32.2(133) 
 
55.69(230) 
 
Dementia 
VS. 
No dementia  
10.8(472) 
0.12 
 
24.9(1089) 
<0.01 
 
 
 
 
50.77(2217) 
0.06 
       
14.4(157) 32.1(349) 
 
53.26(580) 
 
Clinical 
delirium 
VS. 
No clinical 
delirium 
 
10.0(370) 
<0.01 
 
23.7(873) 
<0.01 
 
 
50.58(1867) 
0.12 
       
12.9(41) 36.3(115) 
 
53.94(171) 
 
FSD 
VS. 
No FSD 10.9(486) 
0.26 
24.8(1107) 
<0.01 
 
 51.00(2276) 
0.31 
 
 
       
10.3(82) 29.9(238) 51.01(406) CI 
VS. 
No CI 
 
11.2(445) 
0.48 
 
24.7(984) 
<0.01 
 
 
 
51.23(2041) 
0.91 
 
 
 
*   Chi-square test 
3.4 Cox’s Regression Model for All-cause Mortality 
Table 3.6shows the results of Cox’s regression model. In unadjusted Cox’s 
model, the hazard of death was associated with dementia, clinical delirium, FSD and 
CI as well as some demographic factors. When adjusting for the four disease 
conditions, age, gender, CCI and SIMD,  the hazard of death for patients with 
dementia was estimated to decrease slightly from 1.42 to 1.17 with a 95% confidence 
interval of 1.00 -1.38 . Similarly, those with clinical delirium had 1.23 times greater 
hazard ratio (HR) to death (95% CI: 1.10-1.37) which also declined from 1.39 when 
no factors were adjusted for. Although FSD and CI were shown to significantly 
increase the risk of death with hazard ratios of 1.53 and 1.35 by themselves, they 
were not significant predictors anymore in the adjusted model.  Age, male gender 
and CCI always significantly contributed to predicting the hazard of death no matter 
what was adjusted for. With age and CCI increasing, the hazard of death also rose. 
Besides, there would be about 20% increase for mortality if the patient was male in 
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adjusted model. SIMD was shown to be non-significant with hazard of death neither 
individually nor in the multiple variables regression model. 
Table 3.6Hazard ratios for all-cause mortality from Cox’s regression model, with 
adjustment for all variables 
  Unadjusted   Adjusted   
  HR 95%CI P-
value 
HR 95%CI P-
value 
Dementia  1.42 1.22-
1.66 
<0.01 1.17 1.00-
1.38 
<0.05 
        
Clinical 
delirium 
 1.39 1.25-
1.55 
<0.01 1.23 1.10-
1.37 
<0.01 
        
FSD  1.53 1.30-
1.81 
<0.01    
        
CI  1.35 1.20-
1.52 
<0.01    
        
66-75 1 1  
76-85 1.34 1.18-
1.54 
<0.01 1.34 1.17-
1.54 
<0.01 
86-95 1.80 1.57-
2.06 
<0.01 1.86 1.62-
2.14 
<0.01 
Age group 
95+ 2.39 1.87-
3.04 
<0.01 2.75 2.15-
3.53 
<0.01 
    
Female 1 1 gender 
Male 1.21 1.10-
1.33 
<0.01 1.20 1.09-
1.32 
<0.01 
    
0  1 1 
1-2 1.54 1.35-
1.77 
<0.01 1.50 1.31-
1.73 
<0.01 
3-4 2.28 1.94-
2.68 
<0.01 2.10 1.78-
2.48 
<0.01 
CCI 
5+ 6.80 5.76-
8.02 
<0.01 7.04 5.96-
8.32 
<0.01 
      
Least 
deprived  
1    
0-20% 1.05 0.88-
1.25 
0.61    
20-40%  1.12 0.94-
1.33 
0.21    
40-60%  1.15 0.96-
1.38 
0.12    
SIMD 
60-80%  1.14 0.94-
1.39 
0.18    
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Table 3.7 toTable 3.10shows the comparison of hazard ratio between 
unadjusted model and adjusted model with only one condition factor individually 
involved each time. Even though there were slight decrease for the hazard ratio of 
dementia (HR: 1.23; 95%CI: 1.05-1.44; P=0.01) and clinical delirium (HR: 1.25; 
95%CI: 1.12-1.40; P<0.01), they were still significant factors for mortality (Table 
3.7and Table 3.8). However, the association between FSD and death stayed 
significant when the Cox’s model was adjusted by FSD individually as well as 
gender, CCI and SIMD (HR: 1.31, 95%CI: 1.10-1.55; P<0.01) (Table 3.9). Similarly, 
association with CI persisted significantly in adjusted models which would increase 
mortality by 20% for patients with CI (Table 3.10). 
Table 3.7Hazard ratio of all-cause mortality for dementia patients from Cox’s 
regression model 
   Unadjusted   Adjusted   
  HR 95%CI P-
value 
HR 95%CI P-
value 
Dementia  1.42 1.22-1.66 <0.01 1.23 1.05-1.44 0.01 
        
66-75 1 1 
76-85 1.34 1.18-1.54 <0.01 1.36 1.19-1.56 <0.01 
86-95 1.80 1.57-2.06 <0.01 1.92 1.67-2.21 <0.01 
Age group 
95+ 2.39 1.87-3.04 <0.01 2.82 2.20-3.61 <0.01 
    
Gender Female 1 1 
 Male 1.21 1.10-1.33 <0.01 1.20 1.09-1.32 <0.01 
        
0 1 1 
1-2 1.54 1.35-1.77 <0.01 1.51 1.31-1.73 <0.01 
3-4 2.28 1.94-2.68 <0.01 2.12 1.80-2.50 <0.01 
CCI 
5+ 6.80 5.76-8.02 <0.01 7.08 5.99-8.38 <0.01 
      
Least 
deprived 
1    
0-20% 
Most 
deprived 
1.05 0.88-1.25 0.61    
20-40% 1.12 0.94-1.33 0.21    
40-60% 1.15 0.96-1.38 0.12    
SIMD 
60-80% 1.14 0.94-1.39 0.18    
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Table 3.8Hazard ratio of all-cause mortality for clinical delirium from Cox’s 
regression model 
  Unadjusted   Adjusted   
  HR 95%CI P-
value 
HR 95%CI P-
value 
Clinical 
delirium 
 1.39 1.25-1.55 <0.01 1.25 1.12-1.40 <0.01 
        
66-75 1 1 
76-85 1.34 1.18-1.54 <0.01 1.34 1.17-1.54 <0.01 
86-95 1.80 1.57-2.06 <0.01 1.90 1.65-2.18 <0.01 
Age 
group 
95+ 2.39 1.87-3.04 <0.01 2.81 2.19-3.60 <0.01 
        
Female 1   1   Gender 
Male 1.21 1.10-1.33 <0.01 1.20 1.08-1.32 <0.01 
   
0 1 1 
1-2 1.54 1.35-1.77 <0.01 1.53 1.33-1.75 <0.01 
3-4 2.28 1.94-2.68 <0.01 2.14 1.82-2.52 <0.01 
CCI 
5+ 6.80 5.76-8.02 <0.01 7.07 5.98-8.36 <0.01 
      
Least 
deprived 
1    
0-20% 
Most 
deprived 
1.05 0.88-1.25 0.61    
20-40% 1.12 0.94-1.33 0.21    
40-60% 1.15 0.96-1.38 0.12    
SIMD 
60-80% 1.14 0.94-1.39 0.18    
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Table 3.9Hazard ratio of all-cause mortality for FSD patients from Cox’s regression 
model 
  Unadjusted   Adjusted   
  HR 95%CI P-
value 
HR 95%CI P-
value 
FSD  1.53 1.30-1.81 <0.01 1.31 1.10-1.55 <0.01 
 
        
66-75 1 1 
76-85 1.34 1.18-1.54 <0.01 1.35 1.18-1.55 <0.01 
86-95 1.80 1.57-2.06 <0.01 1.91 1.67-2.20 <0.01 
Age 
group 
95+ 2.39 1.87-3.04 <0.01 2.86 2.23-3.66 <0.01 
    
Female 1 1 Gender 
Male 1.21 1.10-1.33 <0.01 1.19 1.08-1.32 <0.01 
    
0 1 1 
1-2 1.54 1.35-1.77 <0.01 1.55 1.35-1.78 <0.01 
3-4 2.28 1.94-2.68 <0.01 2.18 1.85-2.56 <0.01 
CCI 
5+ 6.80 5.76-8.02 <0.01 7.08 5.99-8.38 <0.01 
      
Least 
deprived 
1    
0-20% 
Most 
deprived 
1.05 0.88-1.25 0.61    
20-40% 1.12 0.94-1.33 0.21    
40-60% 1.15 0.96-1.38 0.12    
SIMD 
60-80% 1.14 0.94-1.39 0.18    
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Table 3.10Hazard ratio of all-cause mortality for CI patients from Cox’s regression 
model 
  Unadjusted   Adjusted   
  HR 95%CI P-
value 
HR 95%CI P-
value 
CI  1.35 1.20-1.52 <0.01 1.19 1.05-1.34 0.01 
 
        
66-75 1 1 
76-85 1.34 1.18-1.54 <0.01 1.35 1.18-1.55 <0.01 
86-95 1.80 1.57-2.06 <0.01 1.90 1.65-2.19 <0.01 
Age 
group 
95+ 2.39 1.87-3.04 <0.01 2.76 2.15-3.54 <0.01 
        
Female 1   1   Gender 
Male 1.21 1.10-1.33 <0.01 1.20 1.08-1.32 <0.01 
    
0 1 1 
1-2 1.54 1.35-1.77 <0.01 1.54 1.34-1.76 <0.01 
3-4 2.28 1.94-2.68 <0.01 2.17 1.84-2.55 <0.01 
CCI 
5+ 6.80 5.76-8.02 <0.01 7.13 6.03-8.43 <0.01 
     
Least 
deprived 
1    
0-20% 
Most 
deprived 
1.05 0.88-1.25 0.61    
20-40% 1.12 0.94-1.33 0.21    
40-60% 1.15 0.96-1.38 0.12    
SIMD 
60-80% 1.14 0.94-1.39 0.18    
 
3.5 Checking Proportional Hazards Assumption 
Figure 3.9 illustrates the results of proportional hazards assumption 
assessment for clinical delirium. It was found that there were apparently peak values 
on the graph before 300 days and the plots basically trend to be a more horizontal 
line after that, even though the assumption was non-significant. For a smoother curve, 
the patients were divided into two groups, one was clinical delirium patients survived 
less than 300 hundred days, and another was clinical delirium patients survived more 
than 300 days. Assessment of the proportional hazard ratios with these new groups 
can be seen fromFigure 3.10 and Figure 3.11. Both time periods had non-significant 
results (P=0.64 for less than 300 days; P= 0.21 for more than 300 days) which means 
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the validity of the proportional hazards model with these new time periods is 
improved. The result of Cox’s regression model for clinical delirium with interacting 
survival time adjusted dementia, age, gender and CCI can be seen fromTable 3.11. 
For patients who had clinical delirium, the risk of death was 4.44(95%CI: 3.93-5.03) 
for the first 300 days. However, if they survive more than 300 days, the risk would 
decrease markedly. 
 
Figure 3.9Standardized Score Process for clinical delirium. 
51 
 
 
Figure 3.10Standardized Score Process for clinical delirium with less than 300 days 
survive. 
 
Figure 3.11Standardized Score Process for clinical delirium with more than 300 days 
survive. 
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Table 3.11Hazard Ratio of all-cause mortality for clinical delirium from Cox’s 
regression model 
  HR 95%CI P-value 
66-75 1 
76-85 1.31 1.14-1.50 <0.01 
86-95 1.74 1.52-2.01 <0.01 
Age group 
95+ 2.48 1.93-3.17 <0.01 
   
0 1 
1-2 1.46 1.27-1.68 <0.01 
3-4 2 1.70-2.36 <0.01 
CCI 
5+ 5.67 4.79-6.72 <0.01 
     
Clinical delirium 
live less than 300 
days 
 4.44 3.93-5.03 <0.01 
     
Clinical delirium 
live more than 
300 days 
 0.2 0.15-0.26 <0.01 
3.6 Cox’s Regression Model for Mortality due to 
Respiratory Conditions and CVD and Survival Curves 
 
 
Table 3.12and  
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Table 3.13show the Cox’s regression models’ results for the relationship 
between mortality due to respiratory conditions and CVD separately and adjusted for 
patient’s cognitive condition, gender, CCI and SIMD. As a result, neither of 4 
cognitive conditions was related to the death due to respiratory disease. However, 
male gender would significantly increase the risk of dying with respiratory disease by 
68 %(HR: 1.68, 95%CI: 1.32-2.12, P<0.01). Only CI was estimated to having a 
significant relationship with co-mortality of CVD. The hazard ratio was 
1.47(95%CI:1.20-1.79,P<0.01), which mean for patients with CI, the risk of dying as 
CVD was 47% of higher than patients without CI. Figure 3.12was the survival curves 
of CVD co-mortality compared with CI and no CI. It can be easily found the 
difference of survival ability between them, and noCI did better in survival.  
 
 
Table 3.12Hazard ratio of Respiratory co-mortality from Cox’s regression model 
  HR 95%CI P-value 
66-75 1 
76-85 1.42 1.03-1.96 0.03 
86-95 2.03 1.46-2.82 <0.01 
Age group 
95+ 1.98 1.00-3.90 0.05 
   
Gender Female 1 
 Male 1.68 1.32-2.12 <0.01 
   
0 1 
1-2 1.84 1.35-2.50 <0.01 
3-4 2.06 1.41-3.01 <0.01 
CCI 
5+ 0.55 0.22-1.39 0.21 
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Table 3.13Hazard ratio of CVD co-mortality from Cox’s regression model 
  HR 95%CI P-value 
CI  1.47 1.20-1.79 <0.01 
   
66-75 1 
76-85 2.02 1.47-2.77 <0.01 
86-95 3.42 2.50-4.68 <0.01 
Age group 
95+ 5.72 3.66-8.94 <0.01 
   
0 1 
1-2 1.9 1.46-2.46 <0.01 
3-4 2.82 2.09-3.81 <0.01 
CCI 
5+ 1.97 1.18-3.27 0.01 
 
 
Figure 3.12Kaplan-Meier survival Curves of CVD co-mortality for patients with and 
without CI (0: no CI; 1: CI) 
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4. Discussion 
4.1 Quality assessment tool 
The assessment of risk of bias due to confounding is likely to be associated 
with heterogeneity between the studies. The STROBE checklist was used to assess 
the quality of the papers finally included. It is a common form of assessment of the 
quality of observational studies. It may be more suitable though for journal editors 
and reviewers to assess observational studies submitted to journals. In this review, 
the involved papers included one randomised controlled study. However, it may not 
be appropriate for STROBE to be used in assessing the risk of bias of the studies 
included. Usually, the Cochrane Collaboration tool and Newcastle-Ottowaare more 
appropriate in assessing quality and risk of bias for randomised trials and 
observational studies respectively. The latter would have been a better tool to use for 
this dissertation. 
4.2 Missing data 
As the dataset which was used for analysis in this dissertation was obtained 
directly from the statistician Professor Peter Donnan, the data had already gone 
through a selection process and was already clean. However, this meant that the data 
represented about 80% of all the potential admissions as 20% had missing data, so 
there is some possibility of bias in the results, although this percentage of missing 
would not be considered large. 
4.3 Summary of Results 
Outcomes of confusion  
The prevalence of clinical delirium was almost 3.5 times bigger than the 
prevalence of FSD. It may be because there was a misdiagnosis for clinical delirium  
This may provide further evidence for the poor management of delirium in clinical 
settings(45).  
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The prevalence of dementia, delirium and CI was relatively low compared 
with the studies included in the literature review. Maybe there was some bias during 
the sample selection for some of the papers which were involved in the literature 
review.  For example, Sampson et al. (16)excluded patients who were confirmed to 
have delirium during the selection process. There was also a sub-sample assessment 
by a clinician in Whittamore’s study (19). This kind of second selection process may 
reduce the representativeness of the results. The results from this selection method 
can only then represent the more focussed sample of the study. If we want to promote 
the results to the population, the sampling procedure should be taken into account. 
However, the dataset I used had linked almost all the emergency admissionsin NHS 
Fife without selection. In addition, the assessment of confusion has become one of 
the routine assessments for NHS Fife emergency admission.  As a result, the 
prevalence of dementia, delirium and CI which we got could truly represent the 
prevalence of all acutely admitted elderly in Fife. This may explain the consistence 
of prevalence of dementia of our study with Draper’s (23) result. His study also came 
from a patient care admissions database, which avoids the bias fromgreater focussed 
selection. 
As expected, the population with the four conditions were always 
significantly older, had shorter survival times and higher mortality than peoplewith 
no conditions. Other characteristic differences between each kind of confusion 
patients and no confusion people existed as well, although varied each other. 
Dementia was more likely with female patients and dementia patients suffered more 
illness than people with no dementia. The latter point was consistent with results of 
other papers (28, 50), which found dementia was associated with many more 
comorbidities and more serious illness. The difference of 30 days’ mortality for 
people with dementia and no dementia was 2.5%, but it was not significant. This 
result did not agree with the results of the Meta-analysis which I had done 
previously. It may be made worse by the significant heterogeneity of the papers in 
the Meta-analysis. As I mentioned before, Sampson’s papers (16, 17) excluded 
delirium patients from the sample to concentrate on those with dementia. So the 
mortality was higher than other studies. Guijarro’s paper was conducted for 5 years, 
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which may also cause the high mortality. So it may make less sense to compare the 
mortality related to dementia in Fife to the results of the Meta-analysis. 
The overlapping between cognitive impairment, dementia and delirium were 
inevitable in a clinical environment. Taking consideration of this, I believed this will 
affectthe hazard of mortality. Many factors should be considered, before 
conclusionscan be made. 
Survival analyses 
In the Cox model, only dementia, clinical delirium, age group, female gender 
and CCI were estimated to be the risk factors for death when adjusted for SIMD.  
The influence of FSD and CI on death was lost when adjusted for other factors. 
Firstly, in this study, ‘general clinical delirium’ and ‘FSD’ were both used to assess 
delirium. The definition of ‘general clinical delirium’ during the study was bound to 
give a higher population. This may weaken the impact of ‘FSD’ in adjusted analyses. 
Second, that mild CI was a marker of dementia has been confirmed by many studies 
(51, 52). CI was more often used for describing the early phase of dementia as the 
symptoms develop. As a result, when dementia and CI were both involved in one 
regression model, the influence of CI was reduced to become non-significant. 
In testing for proportional hazards 300 days was found to be a key time point 
for clinical delirium patients during the admission in terms of mortality.  As far as I 
know no similar result has been found. Once a patient has clinical delirium, CI may 
progress, be stable or reverse. Some previous studies have reported  that there may be 
up to 50% of patients with CI who could improve their cognition status over 1 to 3 
years(53, 54). These results all suggested that early detection of CI can contribute to 
the decrease of the mortality by early recognition and treatment of delirium. 
Chronic disease and confusion 
Dementia, cognitive impairment and delirium have been shown to be highly 
prevalent with many chronic diseases, including obstructive pulmonary disease(55), 
vascular disease(50) and cancer(56). We focused on mortality from Respiratory 
disease and CVD as outcomes. As a result, only CI was found to be related to CVD 
when adjusted for other factors, which also suggested that CI may increase the risk of 
patients dying with CVD or at least may be a marker of deterioration.  The 
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comparison between the CVD mortality in CI and no CI also demonstrated this point. 
This result was also consistent with the study conducted by Martin et al.(57), which 
suggested cognitive impairment increases the risk of cardiovascular disease and 
mortality. 
4.4 Strengths 
This study is unique since I took advantage of the dataset of NHS Fife CGA 
programme to assess the current prevalence of confusion status and explored the 
relationship between all types of confusion and death. I have also linked the SMR01 
dataset, GRO dataset and the CHI dataset, which guaranteed record-linkage and 
complete data. Besides, all the analysis was conducted under the Safe Haven within 
HIC , which guaranteed security and confidentiality. Investigation of all types of 
confusion status were assessedwhich is difficult as they easily overlap and generally 
always are underestimated during clinical settings. In my study, I not only have 
defined dementia, delirium and CI separately from each other, we also defined 
general clinical delirium and FSD to explore the diagnostic level of delirium in 
clinical settings.  Besides, I explored all the patients admitted into hospital with a 
variety of diagnoses and then determined the prevalence of each kind of condition. 
So the outcomes of our study may be more representative than other studies.  
4.5 Weaknesses 
There are several weaknesses in this study. First, as a cohort study, the 
follow-up time for the study was relatively short. Even in the best case, the maximum 
follow up length was only 21 months. Second, readmission rates and hospital length 
of stay were both vital clinical variables for estimating the influence of confusion 
status. However, they were not included in this study but could be in future studies. 
Third, before my analysis, I did not realise there was missing information for 20% of 
all admissions which may have introduced some bias.  
The cut point of 300 days in proportional hazards ratio was the result of many 
attempts at data fitting. It is not an exact time point, andmay differ with new datasets. 
More work could be done to make this cut point more accurate. 
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4.6 Implications for management of elderly patients 
From my study, I found that hazard for death was related to a specific time 
period for identifying and controlling clinical delirium, which was 300 days. It means 
there will be around 10 month of time for physicians to positively diagnose and 
manage clinical deliriumin the patients by pharmacology or other therapies. The 
earlier thecontrol ofclinical delirium, the lower the mortality for the patients.In 
addition, the result of cognitive impairment increasing the risk of cardiovascular 
disease and mortality should be taken seriously by all stakeholders. It should receive 
more attention to prevent cardiovascular disease for cognitively impaired patients 
during clinical care. 
4.7 Further work 
The meta-analysis could be repeated with only one of Sampson’s papers 
instead of the two included. It was not clear that the second paper contained new 
results. Some results of patients within combinations of the confusion 
conditionscould be explored further.Further analysiscould be done to analyse the 
influence of the factors of dementia, CI and clinical delirium onthe rehospitalisation 
rate and length of stay in hospital. Such a studyshould be followed up for more years 
to detect the long-term influence of these factors on clinical outcomes of patients. In 
these studies, competing risks would be an issue as death would alter the risk of 
rehospitalisation, for example.A clinical prediction model could also be designed to 
estimate risk of death within one year, which can help clinicians identify those at 
high risk andfacilitate decisionsand arrange appropriate interventions. 
4.8 Summaries 
During hospital admissions for the elderly, the four confusion conditions are 
prevalent worldwide. Each condition is related to worse outcomes in general hospital 
settings. People with dementia, delirium, cognitive impairment and FSD always do 
badly in terms of survival time. Dementia and delirium indeed have independent 
significant influence on mortality when other factors are taken into account in an 
adjusted Cox regression model. It is crucial to identify CI in a timely way, which 
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potentially could decrease mortality. For patients who have already been diagnosed 
with some chronic diseases, it will also benefit them if their CI can be detected 
earlywithpossible treatment earlier. 
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Appendix 2 the Region Map of Fife Scotland 
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Appendix 3 Acute Comprehensive Geriatric 
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Appendix 4the Local SIMD Summary for Fife 
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Appendix 5SAS Syntax for Data Analysis 
libnamealldata'Z:\test'; 
libnamexportoutxport'Z:\test\CGA_all_admissions.xpt'; 
dataalldata.xportout; 
setxportout.cga_all_; 
run; 
dataalldata.partly; 
setalldata.xportout (keep= prochi sex age ADMISSIO  
DISCHARG SIMD_SCT  SIMD_SC2 DEMENTI2); 
run; 
/*in this prosess I first set a new excel documents which 
contain the varibles I want, and then import it*/ 
dataALLDATA.useful    ; 
infile'Z:\test\CGA_useful.csv'delimiter = 
','MISSOVERDSDlrecl=32767firstobs=2 ; 
informatprochi$10. ; 
informat sex $1. ; 
informat age best32. ; 
informatadmission_date_detailddmmyy10. ; 
informatdischarge_date_detailddmmyy10. ; 
informatsimd_sct_quintilebest32. ; 
informatsimd_sct_decilebest32. ; 
informat dementia best32. ; 
informatgen_clinical_deliriumbest32. ; 
informatgen_FSDbest32. ; 
informatgen_CIbest32. ; 
informat CCI best32. ; 
formatprochi$10. ; 
format sex $1. ; 
format age best12. ; 
formatadmission_date_detailddmmyy10. ; 
formatdischarge_date_detailddmmyy10. ; 
formatsimd_sct_quintilebest12. ; 
formatsimd_sct_decilebest12. ; 
format dementia best12. ; 
formatgen_clinical_deliriumbest12. ; 
formatgen_FSDbest12. ; 
formatgen_CIbest12. ; 
format CCI best12. ; 
input 
prochi $ 
sex $ 
age 
admission_date_detail 
discharge_date_detail 
simd_sct_quintile 
simd_sct_decile 
dementia 
gen_clinical_delirium 
gen_FSD 
gen_CI 
                  CCI; 
 
run; 
/*import the death and ICD data*/ 
 
data ALLDATA.USEFUL2    ; 
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infile'P:\Project 2702- NHS Fife Comprehensive Geriatric 
Assessment\jzang2702\CGA 
 Jinnan\Project_2702_GRO_CGA_Cohort.csv'delimiter = 
','MISSOVERDSDlrecl=32767firstobs=2; 
informat PROCHI $10. ; 
informatdate_of_death_GROddmmyy10. ; 
informaticdcucd$4. ; 
informat icdrcd0 $4. ; 
informat icdrcd1 $4. ; 
informat icdrcd2 $4. ; 
informat icdrcd3 $4. ; 
informat icdrcd4 $4. ; 
informat icdrcd5 $4. ; 
informat icdrcd6 $4. ; 
informat icdrcd7 $4. ; 
informat icdrcd8 $4. ; 
informat icdrcd9 $4. ; 
informathb_codebest32. ; 
informatdt_regddmmyy10. ; 
informatinst_code$5. ; 
format PROCHI $10. ; 
formatdate_of_death_GROddmmyy10. ; 
formaticdcucd$4. ; 
format icdrcd0 $4. ; 
format icdrcd1 $4. ; 
format icdrcd2 $4. ; 
format icdrcd3 $4. ; 
format icdrcd4 $4. ; 
format icdrcd5 $4. ; 
format icdrcd6 $4. ; 
format icdrcd7 $4. ; 
format icdrcd8 $4. ; 
format icdrcd9 $4. ; 
formathb_codebest12. ; 
formatdt_regddmmyy10. ; 
formatinst_code$5. ; 
input 
                   PROCHI $ 
date_of_death_GRO 
icdcucd $ 
                   icdrcd0 $ 
                   icdrcd1 $ 
                   icdrcd2 $ 
                   icdrcd3 $ 
                   icdrcd4 $ 
                   icdrcd5 $ 
                   icdrcd6 $ 
                   icdrcd7 $ 
                   icdrcd8 $ 
                   icdrcd9 $ 
hb_code 
dt_reg 
inst_code $; 
run; 
/*keep the variable I want from dataset*/ 
data alldata.useful2; 
set alldata.useful2(keep=PROCHI date_of_death_GROicdcucd 
icdrcd0); 
run; 
procsortdata=alldata.useful2 ; 
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by PROCHI; 
run; 
/*as the data in useful2 include a record with missing*/ 
data alldata.useful2; 
set alldata.useful2; 
ifdate_of_death_GRO="."thendelete; 
run; 
procsortdata=alldata.useful ; 
by PROCHI; 
run; 
/*merge two dataset together, but useful2 may have people 
who are not followed up, we need delete them*/ 
dataalldata.whole; 
mergealldata.useful(in=a) alldata.useful2(in=b); 
by PROCHI ; 
if not a thendelete; 
run; 
/*set a new variable to show if the patient has been dead*/ 
data alldata.whole1; 
setalldata.whole; 
ifdate_of_death_GRO=" "then death=0; 
else death=1; 
run; 
/*if patient have two record,we just keep the first 
record*/ 
data alldata.whole1; 
set alldata.whole1; 
by PROCHI; 
first=first.PROCHI; 
last=last.PROCHI; 
run; 
/*KEEP THE FIRT VISIT RECORD*/ 
data try; 
set alldata.whole1; 
by PROCHI; 
iffirst.PROCHIthencnt=0; 
cnt+1; 
ifcnt<=1; 
run; 
datasigle dup; 
set alldata.whole1; 
by PROCHI; 
iffirst.PROCHI and last.PROCHIthenoutputsigle; 
elseoutput dup; 
run; 
 
/*set 4*4 tables with dementia,gen_clinical_delirium 
,gen_FSD,gen_CI,CCI,death*/ 
procfreqdata=try ; 
tables sex*dementia / chisq;  
title gender and dementia; 
run; 
procfreqdata=try ; 
tables sex*gen_clinical_delirium/ chisq;  
title gender and clinical delirium; 
run; 
procfreqdata=try ; 
tables sex*gen_FSD/ chisq;  
title gender and fully syndromic delirium; 
run; 
procfreqdata=try; 
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tables sex*gen_CI/ chisq;  
title gender and cognitive impairment; 
run; 
procfreqdata=try; 
tables sex*death/ chisq;  
title gender and death; 
run; 
procfreqdata=try; 
tables sex*CCI/ chisq;  
title gender and charlson comorbidity index; 
run; 
/*to find the start date and end date of the record,start 
date(01/01/2012) end date(30/09/2013)*/ 
procsortdata=work.try; 
bydate_of_death_GRO; 
run; 
/*if the patient still alive until the end,modify their 
missing data into the end date(30/09/2013)*/ 
data try; 
set try; 
ifdate_of_death_GRO=.thendate_of_death_GRO="30SEP2013"D; 
run; 
/*delete the false record*/ 
data try; 
set try; 
ifdate_of_death_GRO<"01JAN2012"Dthendelete; 
run; 
/*set a new variable named survival_time,look out there 
should be a +1, in case of the patient dead same day*/ 
data try; 
set try; 
survival_time=date_of_death_GRO-admission_date_detail+1; 
run; 
procsortdata=work.try; 
by PROCHI; 
run; 
/*plot Kaplan-Meier estimator and its 95% confidence 
interval, with people with and without dementia, also have a log-
test*/ 
 
odshtmlgpath='z:\\survival graphs'; 
odsgraphicson / outputfmt =jpeg; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
strata dementia / test= (all); 
title Kaplan-Meier estimator of dementia; 
run; 
 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
stratagen_clinical_delirium/ test= (all); 
title Kaplan-Meier estimator of gen_clinical_delirium; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
stratagen_FSD/ test= (all); 
title Kaplan-Meier estimator of gen_FSD; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
stratagen_CI/ test= (all); 
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title Kaplan-Meier estimator of gen_CI; 
run; 
/*to compare between age, seperate age into 4 group*/ 
data try; 
set try; 
if65< age <=75thenage_group=1; 
elseif75< age <=85thenage_group=2; 
elseif85< age <=95thenage_group=3; 
 elseif95<age thenage_group=4; 
run; 
data try; 
set try; 
if CCI=0thenCCI_cat=1; 
elseif1<= CCI <=2thenCCI_cat=2; 
elseif3<= CCI <=4thenCCI_cat=3; 
 elseif5<= CCI thenCCI_cat=4; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
strataage_group/ test= (all); 
title Kaplan-Meier estimator of age_group; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
strataCCI_cat/ test= (all); 
title Kaplan-Meier estimator of charlson comorbidity index; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
strata  sex/ test= (all); 
title Kaplan-Meier estimator of sex; 
run; 
proclifetestdata=try plots=(survival (cl)); 
timesurvival_time*death(0); 
stratasimd_sct_quintile/ test= (all); 
title Kaplan-Meier estimator of SIMD; 
run; 
procfreqdata=try ; 
tables dementia*gen_clinical_delirium*gen_CI/ chisq;  
title mix three table; 
run; 
/*To do the characteristics analyse withe the 
ANOVA(univariate) and chi square(chisq) test*/ 
data try; 
set try; 
procunivariatedata=try ; 
class dementia; 
var CCI; 
run; 
procfreqdata=try ; 
tablesCCI_cat*dementia/ chisq;  
run; 
/*Cox's regression model, with  the first value as the 
refernce*/ 
procphregdata=try ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rlselection=b; 
run; 
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/*Cox's proportional hazard ratio test  (with "assess" 
statement)*/ 
odshtmlgpath='z:\\PH HR'; 
odsgraphicson / outputfmt =jpeg; 
procphregdata=try ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rlselection=b; 
assessph/ resample; 
run; 
/*use sperarman relation test to fit the relationship 
between CI and dementia/clinical delirium/FSD */ 
proccorrdata=try spearman; 
var dementia gen_CI; 
run; 
proccorrdata=try spearman; 
vargen_clinical_deliriumgen_CI; 
run; 
proccorrdata=try spearman; 
vargen_FSDgen_CI; 
run; 
proccorrdata=try spearman; 
vargen_FSDgen_clinical_delirium; 
run; 
proccorrdata=try spearman; 
vargen_FSD dementia; 
run; 
proccorrdata=try spearman; 
vargen_clinical_delirium dementia; 
run; 
/*fit the cox's model with just one condition itself*/ 
procphregdata=try ; 
class dementia  age_group sex CCI_catsimd_sct_quintile 
/ref=first ; 
modelsurvival_time*death(0)=  dementia   
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
procphregdata=try ; 
classgen_clinical_deliriumage_group sex 
CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)=  gen_clinical_delirium 
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
procphregdata=try ; 
classgen_FSDage_group sex CCI_catsimd_sct_quintile 
/ref=first ; 
modelsurvival_time*death(0)=   gen_FSD 
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
procphregdata=try ; 
classgen_CIage_group sex CCI_catsimd_sct_quintile 
/ref=first ; 
modelsurvival_time*death(0)=  gen_CI 
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
/*fit the cox's model with each factor*/ 
procphregdata=try ; 
classsimd_sct_quintile /ref=last ; 
modelsurvival_time*death(0)=  simd_sct_quintile/rl ; 
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/*extracted RESP and CVD from ICD, do Kaplan-Meir plots for 
co-mortality of CVD*/ 
data ICD; 
set try; by PROCHI; 
ICD= put (icdcucd,4.-L); 
adm=substr(ICD,1,1); 
formatadm$4.; 
run; 
data ICD; 
set ICD; 
ifadm= "J"thendeath_reason= "RESP"; 
elseifadm= "I"thendeath_reason= "CVD"; 
elseifadm= " "thendeath_reason= " "; 
elsedeath_reason= "OTHERS"; 
run; 
data ICD; 
set ICD; 
ifdeath_reason= "RESP"then RESP= 1; 
else RESP= 0; 
run; 
data ICD; 
set ICD; 
ifdeath_reason= "CVD"then CVD= 1; 
else CVD= 0; 
run; 
odshtmlgpath='z:\\survival graphs'; 
odsgraphicson / outputfmt =jpeg; 
proclifetestdata=icdplots=(survival (cl)); 
timesurvival_time*CVD(0); 
stratagen_CI / test= (all); 
title Kaplan-Meier estimator of co-mortality of CVD; 
run; 
 
/*Cox's regression model with the icd dataset to test the 
relationahship between co-mortality of RESP and other factorS, 
with  the first value as the refernce*/ 
procphregdata=icd ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile  /ref=first ; 
modelsurvival_time*RESP(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile /rlselection=b; 
run; 
/*Cox's proportional hazard ratio test  (with "assess" 
statement)*/ 
odshtmlgpath='z:\\PH HR'; 
odsgraphicson / outputfmt =jpeg; 
procphregdata=icd ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile  /ref=first ; 
modelsurvival_time*RESP(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile /rlselection=b; 
assessph/ resample; 
run; 
/*Cox's regression model with the icd dataset to test the 
relationahship between co-mortality of CVD and other factorS, 
with  the first value as the refernce*/ 
procphregdata=icd ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile  /ref=first ; 
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modelsurvival_time*CVD(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile /rlselection=b; 
run; 
/*Cox's proportional hazard ratio test  (with "assess" 
statement)*/ 
odshtmlgpath='z:\\PH HR'; 
odsgraphicson / outputfmt =jpeg; 
procphregdata=icd ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile  /ref=first ; 
modelsurvival_time*CVD(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile /rlselection=b; 
assessph/ resample; 
run; 
procphregdata=try ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rlselection=b; 
run; 
data less; 
set try; 
by PROCHI; 
ifsurvival_time>300thendelete; 
run; 
procphregdata=less ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
odshtmlgpath='z:\\PH HR'; 
odsgraphicson / outputfmt =jpeg; 
procphregdata=less ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rl ; 
assessph/ resample; 
run; 
data more; 
set try; 
by PROCHI; 
ifsurvival_time<= 300thendelete; 
run; 
 
procphregdata=more ; 
class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rl ; 
run; 
odshtmlgpath='z:\\PH HR'; 
odsgraphicson / outputfmt =jpeg; 
procphregdata=more ; 
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class dementia gen_clinical_deliriumgen_FSDgen_CIage_group 
sex CCI_catsimd_sct_quintile /ref=first ; 
modelsurvival_time*death(0)= dementia 
gen_clinical_deliriumgen_FSDgen_CI 
age_group sex CCI_catsimd_sct_quintile/rl ; 
assessph/ resample; 
run; 
/*set up a new variable 'time_split', use 300 days. AS WE 
FOUND THAT BEFORE 300 DAYS, THE PROPORTIONAL HAZRD RATIO WAS NOT 
A  
STABLE LINE*/ 
data split; 
set try; 
by PROCHI; 
ifsurvival_time<= 300thentime_split=0; 
elsetime_split=1; 
run; 
/*SET UP TWO NEW VARIABLES 'GCD_GT_300' AND  
'GCD_LT_300','GCD_GT_300' WAS PEOPLE WITH GCD AND SURVIVAL MORE 
THAN 300DAYS 
'GCD_LT_300' WAS PEOPLE WITH GCD AND SURVIVAL LESS THAN 300 
DAYS.*/ 
datasplitnew; 
set split; 
by PROCHI; 
gcd_gt_300=gen_clinical_delirium*time_split; 
gcd_lt_300=gen_clinical_delirium*(1-time_split); 
run; 
 
/* DO THE COX MODEL WITH  'GCD_GT_300'AND 'GCD_LT_300'*/ 
procphregdata=splitnew ; 
class dementia age_group sex CCI_cat  /ref=first ; 
modelsurvival_time*death(0)= dementia   
age_group sex CCI_cat gcd_gt_300 gcd_lt_300 /rl ; 
run; 
/*to check 30 days/ 6 month/ 12 month mortality of 
dementia, delirium and cognitive impairment*/ 
data mortality; 
set try; 
ifsurvival_time<=30then death_30days=1; 
else death_30days=0; 
run; 
data mortality; 
set try; 
ifsurvival_time<=180then death_180days=1; 
else death_180days=0; 
run; 
data mortality; 
set try; 
ifsurvival_time<=360then death_360days=1; 
else death_360days=0; 
run; 
procfreqdata=mortality ; 
tables death_180days* gen_CI / chisq;  
run; 
 
